Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$1.27B |
| 2 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$706M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$439M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$413M |
| 5 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$272M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Weyerhaeuser
WY
|
+$431M |
| 2 |
Walt Disney
DIS
|
+$223M |
| 3 |
VXX
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
|
+$213M |
| 4 |
Halliburton
HAL
|
+$211M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$204M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.24% |
| 2 | Financials | 5.68% |
| 3 | Healthcare | 5.62% |
| 4 | Consumer Discretionary | 5.04% |
| 5 | Industrials | 3.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1901
PUT
Credit Acceptance
CACC
$6.03B
| $4.51M | ﹤0.01% |
10,300
-500
| -5% | -$210K |
|
|
AKCA
1902
PUT
DELISTED
Akcea Therapeutics Inc
AKCA
| $4.51M | ﹤0.01% |
+128,800
| New | +$3.9M |
|
|
JJE
1903
DELISTED
iPath Series B Bloomberg Energy Subindex Total ReturnSM ETN
JJE
| $4.5M | ﹤0.01% |
+80,000
| New | +$4.25M |
|
1904
Allison Transmission
ALSN
$10.3B
| $4.5M | ﹤0.01% |
86,535
-6,639
| -7% | -$311K |
|
1905
CALL
Madrigal Pharmaceuticals
MDGL
$11.9B
| $4.5M | ﹤0.01% |
21,000
+16,900
| +412% | +$4.24M |
|
1906
Emcor
EME
$35.7B
| $4.49M | ﹤0.01% |
59,734
+32,386
| +118% | +$2.5M |
|
|
PPLI
1907
PUT
People Inc
PPLI
$3.03B
| $4.49M | ﹤0.01% |
115,825
-431,965
| -79% | -$14M |
|
1908
FirstCash
FCFS
$9.05B
| $4.48M | ﹤0.01% |
54,685
+25,819
| +89% | +$2.17M |
|
1909
US Foods
USFD
$23.9B
| $4.48M | ﹤0.01% |
145,463
+16,831
| +13% | +$582K |
|
1910
PUT
Carnival Corporation Ltd
CCL
$38B
| $4.48M | ﹤0.01% |
70,300
-85,100
| -55% | -$5.16M |
|
1911
Diana Shipping
DSX
$296M
| $4.48M | ﹤0.01% |
1,556,278
+14,049
| +0.9% | +$42K |
|
1912
Ambarella
AMBA
$3.6B
| $4.48M | ﹤0.01% |
115,710
+2,776
| +2% | +$108K |
|
|
ELLI
1913
DELISTED
Ellie Mae Inc
ELLI
| $4.47M | ﹤0.01% |
47,132
+16,528
| +54% | +$1.7M |
|
1914
iShares MSCI Pacific ex Japan ETF
EPP
$2.26B
| $4.46M | ﹤0.01% |
98,303
-799
| -0.8% | -$36.7K |
|
|
WW
1915
DELISTED
WW International
WW
| $4.46M | ﹤0.01% |
62,015
+49,908
| +412% | +$4.05M |
|
1916
CALL
Microchip Technology
MCHP
$44.2B
| $4.46M | ﹤0.01% |
113,000
+39,000
| +53% | +$1.72M |
|
1917
PUT
Molson Coors Class B
TAP
$7.93B
| $4.45M | ﹤0.01% |
72,400
+23,800
| +49% | +$1.57M |
|
1918
Kemper
KMPR
$1.55B
| $4.44M | ﹤0.01% |
55,231
+43,955
| +390% | +$3.44M |
|
1919
Helen of Troy
HELE
$680M
| $4.44M | ﹤0.01% |
33,932
+29,114
| +604% | +$3.43M |
|
|
SYNH
1920
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $4.43M | ﹤0.01% |
85,932
+38,916
| +83% | +$1.91M |
|
1921
CALL
Lumentum
LITE
$63.3B
| $4.42M | ﹤0.01% |
73,700
-46,400
| -39% | -$2.78M |
|
1922
Peabody Energy
BTU
$3B
| $4.42M | ﹤0.01% |
123,861
+49,165
| +66% | +$2.11M |
|
1923
Okta
OKTA
$26.2B
| $4.41M | ﹤0.01% |
62,700
+25,934
| +71% | +$1.54M |
|
1924
PUT
Viking Therapeutics
VKTX
$4.02B
| $4.41M | ﹤0.01% |
+253,200
| New | +$3.01M |
|
1925
Trinity Industries
TRN
$2.3B
| $4.41M | ﹤0.01% |
167,144
-84,458
| -34% | -$2.22M |
|
Similar funds
Barclays's Q3 2018 Portfolio in Review
As of Q3 2018, Barclays held 7,740 positions worth $144B, up 24% from $116B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Barclays deployed $22.2B of net new capital in Q3 2018, opening 680 new positions and adding to 3,884 existing holdings. Its largest new stake was iPath Series B S&P GSCI Crude Oil ETN: 5,000,000 shares worth $75.7M.
By sector, the portfolio is most concentrated in Technology at 8.2% of assets, up from 7.4% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Weyerhaeuser, an estimated $431M trimmed.
- Barclays's largest Q3 2018 buy was iPath Series B S&P GSCI Crude Oil ETN: 5,000,000 shares worth $75.7M.
- Barclays added most to Fortive in Q3 2018, an estimated $1.27B increase.
- Barclays's biggest Q3 2018 reduction was Weyerhaeuser, cutting an estimated $431M.
- Barclays fully exited Validus Hold Ltd in Q3 2018, selling an estimated $71M.
- Barclays's ten largest holdings make up 31% of its $144B portfolio in Q3 2018.
- Barclays opened 680 new positions and closed 408 in Q3 2018.
- Barclays's portfolio value rose 24% quarter-over-quarter to $144B.
Based on Barclays's 13F filing for Q3 2018, filed 14 Nov 2018.